Skip to main content
. 2018 May 3;32(3):517–522. doi: 10.21873/invivo.11269

Table IV. Progression-free survival and overall survival for patients treated by high total dose total skin electron beam therapy. Overview of the literature.

graphic file with name in_vivo-32-520-i0003.jpg

ATD: Average total dose; mPFS: mean time of progression-free survival; mOS: mean time of overall survival. *Our study included high-dose and low-dose schemes